RUSSIAN AND INTERNATIONAL EXPERIENCE IN THE APPLICATION OF THE JANUS-KINASES INHIBITOR IN RHEUMATOID ARTHRITIS

Abstract

The survey provides data on the use of the only currently available representative of the so-called «small molecules» of the Janus-kinases Inhibitor Tofacitinibe (TOFA) in rheumatoid arthritis (RA) in clinical research and real practice. The positioning of TOFA in the strategy of the RA therapy according to Russian and international clinical recommendations was discussed.

Keywords

• rheumatoid arthritis
• janus-kinase inhibitors
• «small molecules»
• treatment strategy